October 13, 2017 article Open access Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial The Lancet Oncology DOI: 10.1016/s1470-2045(17)30600-9 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 9 stored of 158 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial 2026 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 0 citations The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial 2025 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 16 citations Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial 2024 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 5 citations The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer 2023 JNCI Cancer Spectrum article Medicine Cancer Risks and Factors Open access 8 citations Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial 2023 EClinicalMedicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 16 citations Reply to M. Dowsett et al 2020 Journal of Clinical Oncology letter Pharmacology, Toxicology and Pharmaceutics Pharmaceutical industry and healthcare Open access 0 citations Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials 2020 Journal of Clinical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 43 citations Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial 2020 Breast Cancer Research and Treatment article Medicine Bone health and treatments Open access 8 citations Endocrine Therapy in Early Breast Cancer 2020 Breast Care article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 69 citations 9 results References 0